Advertisement

Topics

Two studies offer additional support to lower systolic blood pressure in high-risk patients

02:22 EDT 24 Aug 2017 | News-Medical.net

Two studies provide additional support for lowering systolic blood pressure to an intensive goal of 120 mmHg – far below the standard guidelines of 140 mmHg – to reduce the risk of heart disease in high-risk patients with hypertension.

Original Article: Two studies offer additional support to lower systolic blood pressure in high-risk patients

NEXT ARTICLE

More From BioPortfolio on "Two studies offer additional support to lower systolic blood pressure in high-risk patients"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Adempas (riociguat)
The United States Food and Drug Administration (FDA) has approved on October 8th 2013 Adempas® (riociguat) tablets for: (i) the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) (WHO* Group 4) after ...